Novel Co-Admin of CAR T Cells Achieves 99% Remission in Leukemia Novel Co-Admin of CAR T Cells Achieves 99% Remission in Leukemia

In the largest study to date of CAR T-cell therapy for relapsed and refractory childhood B-cell acute lymphoblastic leukemia, a novel approach led to undetectable disease in nearly all patients.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news